Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant hyperthermia.

Beverley McNeil1

  • 1Canterbury Christ Church University.

British Journal of Perioperative Nursing : the Journal of the National Association of Theatre Nurses
|September 24, 2005
PubMed
Summary
This summary is machine-generated.

Malignant hyperthermia (MH) is a rare genetic disorder that can occur during anesthesia. Prompt treatment is crucial for survival, necessitating awareness among surgical staff.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beverley McNeil writes on inadvertent hypothermia.

Journal of perioperative practice·2007
Same author

Management of a CJD case. Part 2. The patient with CJD in the operating theatre.

British journal of perioperative nursing : the journal of the National Association of Theatre Nurses·2004
Same author

Management of a CJD case. Part 1. Preoperative organisation of the case.

British journal of perioperative nursing : the journal of the National Association of Theatre Nurses·2004
Same author

Cross infection and the laryngoscope.

British journal of perioperative nursing : the journal of the National Association of Theatre Nurses·2002

Area of Science:

  • Anesthesiology
  • Genetics
  • Pharmacology

Background:

  • Malignant hyperthermia (MH) is a rare, life-threatening genetic disorder.
  • It is often triggered by specific anesthetic agents during surgical procedures.
  • MH presents with hypermetabolism, muscle rigidity, and rapid temperature increase.

Purpose of the Study:

  • To highlight the critical importance of recognizing Malignant hyperthermia (MH) during anesthesia.
  • To emphasize the need for prompt and effective management of MH events.
  • To underscore the necessity of comprehensive training for healthcare professionals regarding MH.

Main Methods:

  • This abstract discusses the clinical presentation and emergency management of Malignant hyperthermia.
  • It synthesizes current understanding of MH triggers and pathophysiology.

Related Experiment Videos

  • The content emphasizes the role of vigilance and preparedness in anesthesia settings.

    • Main Results:

    • Malignant hyperthermia (MH) can be fatal if not treated immediately.
    • Early recognition of symptoms like muscle rigidity and fever is key.
    • Swift administration of dantrolene and supportive care are vital.

    Conclusions:

    • Malignant hyperthermia (MH) is a critical medical emergency requiring immediate intervention.
    • Anesthesia providers must be knowledgeable about MH symptoms and treatment protocols.
    • Preparedness and rapid response are essential to prevent mortality associated with MH.